Cel AI PLC Director’s Dealings
18 March 2024 - 6:00PM
RNS Regulatory News
RNS Number : 1393H
Cel AI PLC
18 March 2024
18 March 2024
CEL AI plc
("Cel AI" or the
"Company")
Director's
Dealings
Cel AI (LSE: CLAI) announces that it
has been notified of the following transactions in ordinary shares
in the Company undertaken by directors/persons discharging
managerial responsibility (PDMRs), details of which are set out in
the notification below.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
|
1.
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Matthew Lodge
|
|
2.
|
Reason for the Notification
|
|
a)
|
Position/status
|
Director
|
|
b)
|
Initial notification /
Amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Cel AI plc
|
|
b)
|
LEI
|
213800IXPX4Z2MKX2U28
|
|
4.
|
Details of the transaction(s):
section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where
transactions have been conducted
|
|
a)
|
Description of the Financial
instrument, type of instrument
|
Ordinary Shares
|
|
|
Identification Code
|
GB00BK964W87
|
|
b)
|
Nature of the transaction
|
Sale of Ordinary Shares
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
0.43 pence per Ordinary
Share
|
10,500,000 Ordinary Shares
(29 February 2024)
|
|
0.375 pence per Ordinary
Share
|
500,000 Ordinary Shares
(06 March 2024)
|
|
0.3526 pence per Ordinary
Share
|
1,200,000 Ordinary Shares
(07 March 2024)
|
|
0.31 pence per Ordinary
Share
|
800,000 Ordinary Shares
(08 March 2024)
|
|
|
d)
|
Aggregated information:
· Aggregated volume
· Price
|
13,000,000
£53,736
|
|
e)
|
Date of the transaction
|
29 February, 06 March, 07 March and
08 March 2024
|
|
f)
|
Place of the Transaction
|
London Stock Exchange
|
For further information please
contact:
|
Cellular Goods
|
|
|
Michael Edwards
Director
|
via
FSCF +44 7572 873 300
|
|
First Sentinel Corporate Finance (FSCF)
|
|
|
Investor Relations
Rebecca Noonan
ir@getcel.ai
Media Relations
Rebecca Noonan
media@getcel.ai
Corporate Broker &
Advisor
Brian Stockbridge
|
+44
7572 873 300
+44
7572 873 300
+44
7858 888 007
|
|
Novum Securities
|
|
|
Corporate Broker
Colin Rowbury
Jon
Belliss
|
+44 207 399 9427
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHJFMTTMTMBTBI
Cel Ai (LSE:CLAI)
Historical Stock Chart
From Dec 2024 to Jan 2025
Cel Ai (LSE:CLAI)
Historical Stock Chart
From Jan 2024 to Jan 2025
